Snoeys J - Search Results

1

Physiologically-Based Pharmacokinetic Modeling in Renal and Hepatic Impairment Populations: A Pharmaceutical Industry Perspective.

Heimbach T, Chen Y, Chen J, Dixit V, Parrott N, Peters SA, Poggesi I, Sharma P, Snoeys J, Shebley M, Tai G, Tse S, Upreti VV, Wang YH, Tsai A, Xia B, Zheng M, Zhu AZX, Hall S. Heimbach T, et al. Among authors: snoeys j. Clin Pharmacol Ther. 2021 Aug;110(2):297-310. doi: 10.1002/cpt.2125. Epub 2020 Dec 30. Clin Pharmacol Ther. 2021. PMID: 33270249 Free PMC article.

2

From preclinical to human--prediction of oral absorption and drug-drug interaction potential using physiologically based pharmacokinetic (PBPK) modeling approach in an industrial setting: a workflow by using case example.

Sinha VK, Snoeys J, Osselaer NV, Peer AV, Mackie C, Heald D. Sinha VK, et al. Among authors: snoeys j. Biopharm Drug Dispos. 2012 Mar;33(2):111-21. doi: 10.1002/bdd.1782. Biopharm Drug Dispos. 2012. PMID: 22383166

3

Evaluation of various static in vitro-in vivo extrapolation models for risk assessment of the CYP3A inhibition potential of an investigational drug.

Vieira ML, Kirby B, Ragueneau-Majlessi I, Galetin A, Chien JY, Einolf HJ, Fahmi OA, Fischer V, Fretland A, Grime K, Hall SD, Higgs R, Plowchalk D, Riley R, Seibert E, Skordos K, Snoeys J, Venkatakrishnan K, Waterhouse T, Obach RS, Berglund EG, Zhang L, Zhao P, Reynolds KS, Huang SM. Vieira ML, et al. Among authors: snoeys j. Clin Pharmacol Ther. 2014 Feb;95(2):189-98. doi: 10.1038/clpt.2013.187. Epub 2013 Sep 18. Clin Pharmacol Ther. 2014. PMID: 24048277

4

The successes and failures of physiologically based pharmacokinetic modeling: there is room for improvement.

Poggesi I, Snoeys J, Van Peer A. Poggesi I, et al. Among authors: snoeys j. Expert Opin Drug Metab Toxicol. 2014 May;10(5):631-5. doi: 10.1517/17425255.2014.888058. Epub 2014 Feb 11. Expert Opin Drug Metab Toxicol. 2014. PMID: 24517185

5

Physiologically based pharmacokinetic modeling in drug discovery and development: a pharmaceutical industry perspective.

Jones HM, Chen Y, Gibson C, Heimbach T, Parrott N, Peters SA, Snoeys J, Upreti VV, Zheng M, Hall SD. Jones HM, et al. Among authors: snoeys j. Clin Pharmacol Ther. 2015 Mar;97(3):247-62. doi: 10.1002/cpt.37. Epub 2015 Jan 9. Clin Pharmacol Ther. 2015. PMID: 25670209 Review.

6

Mechanistic understanding of the nonlinear pharmacokinetics and intersubject variability of simeprevir: A PBPK-guided drug development approach.

Snoeys J, Beumont M, Monshouwer M, Ouwerkerk-Mahadevan S. Snoeys J, et al. Clin Pharmacol Ther. 2016 Feb;99(2):224-34. doi: 10.1002/cpt.206. Epub 2015 Nov 10. Clin Pharmacol Ther. 2016. PMID: 26259716

7

A physiologically based pharmacokinetic modeling approach to predict drug-drug interactions between domperidone and inhibitors of CYP3A4.

Templeton I, Ravenstijn P, Sensenhauser C, Snoeys J. Templeton I, et al. Among authors: snoeys j. Biopharm Drug Dispos. 2016 Jan;37(1):15-27. doi: 10.1002/bdd.1992. Biopharm Drug Dispos. 2016. PMID: 26356245 Clinical Trial.

8

Ibrutinib Dosing Strategies Based on Interaction Potential of CYP3A4 Perpetrators Using Physiologically Based Pharmacokinetic Modeling.

de Zwart L, Snoeys J, De Jong J, Sukbuntherng J, Mannaert E, Monshouwer M. de Zwart L, et al. Among authors: snoeys j. Clin Pharmacol Ther. 2016 Nov;100(5):548-557. doi: 10.1002/cpt.419. Epub 2016 Aug 27. Clin Pharmacol Ther. 2016. PMID: 27367453 Clinical Trial.

9

In vitro and physiologically-based pharmacokinetic based assessment of drug-drug interaction potential of canagliflozin.

Mamidi RNVS, Dallas S, Sensenhauser C, Lim HK, Scheers E, Verboven P, Cuyckens F, Leclercq L, Evans DC, Kelley MF, Johnson MD, Snoeys J. Mamidi RNVS, et al. Among authors: snoeys j. Br J Clin Pharmacol. 2017 May;83(5):1082-1096. doi: 10.1111/bcp.13186. Epub 2016 Dec 20. Br J Clin Pharmacol. 2017. PMID: 27862160 Free PMC article.

10

Elucidating the Plasma and Liver Pharmacokinetics of Simeprevir in Special Populations Using Physiologically Based Pharmacokinetic Modelling.

Snoeys J, Beumont M, Monshouwer M, Ouwerkerk-Mahadevan S. Snoeys J, et al. Clin Pharmacokinet. 2017 Jul;56(7):781-792. doi: 10.1007/s40262-016-0476-2. Clin Pharmacokinet. 2017. PMID: 27896690

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters